Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
Endoscopy remains the reference standard for the diagnosis and assessment of patients
with inflammatory bowel disease (IBD), but it has several important limitations. Cross …
with inflammatory bowel disease (IBD), but it has several important limitations. Cross …
[HTML][HTML] Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making
MT Dolinger, M Kayal - World journal of gastroenterology, 2023 - ncbi.nlm.nih.gov
Intestinal ultrasound (IUS) is a non-invasive, real-time, cross-sectional imaging tool that can
be used at the point-of-care to assess disease activity in patients with Crohn's disease or …
be used at the point-of-care to assess disease activity in patients with Crohn's disease or …
[HTML][HTML] Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn's disease
T Kucharzik, R Wilkens, MA D'agostino… - Clinical …, 2023 - Elsevier
Background & Aims In this STARDUST substudy, the effect of ustekinumab on transmural
bowel inflammation was assessed in adults with moderate-to-severe Crohn's disease (CD) …
bowel inflammation was assessed in adults with moderate-to-severe Crohn's disease (CD) …
Differentiating gastrointestinal tuberculosis and Crohn's disease-a comprehensive review
Abstract Gastrointestinal Tuberculosis (GITB) and Crohn's disease (CD) are both chronic
granulomatous diseases with a predilection to involve primarily the terminal ileum. GITB is …
granulomatous diseases with a predilection to involve primarily the terminal ileum. GITB is …
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus
F D'Amico, F Magro, A Dignass… - Expert Review of …, 2024 - Taylor & Francis
Introduction Although there are well-defined guidelines for the management of mild-to-
moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted …
moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted …
Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective …
F de Voogd, EA van Wassenaer, A Mookhoek, S Bots… - Gastroenterology, 2022 - Elsevier
Abstract Background & Aims Intestinal ultrasound (IUS) is noninvasive, cost-effective, and
accurate to determine disease activity in ulcerative colitis (UC). In this study, we …
accurate to determine disease activity in ulcerative colitis (UC). In this study, we …
Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing
MF Neurath, M Vieth - Gut, 2023 - gut.bmj.com
Mucosal healing on endoscopy has emerged as a key prognostic parameter in the
management of patients with IBD (Crohn's disease, ulcerative colitis/UC) and can predict …
management of patients with IBD (Crohn's disease, ulcerative colitis/UC) and can predict …
Intestinal ultrasound for the pediatric gastroenterologist: a guide for inflammatory bowel disease monitoring in children: expert consensus on behalf of the International …
A Kellar, M Dolinger, KL Novak… - Journal of Pediatric …, 2023 - journals.lww.com
Crohn disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) often
diagnosed in childhood. A strict monitoring strategy can potentially alter the disease course …
diagnosed in childhood. A strict monitoring strategy can potentially alter the disease course …
Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalised patients with severe ulcerative colitis
JFKF Ilvemark, R Wilkens, P Thielsen… - Journal of Crohn's …, 2022 - academic.oup.com
Abstract Background and Aims Our aim was to determine if transabdominal intestinal
ultrasound changes after 48±24 h of intravenous corticosteroids can predict treatment …
ultrasound changes after 48±24 h of intravenous corticosteroids can predict treatment …
Single-center experience with upadacitinib for adolescents with refractory inflammatory bowel disease
EA Spencer, S Bergstein, M Dolinger… - Inflammatory Bowel …, 2024 - academic.oup.com
Background Upadacitinib (UPA) is a novel selective JAK inhibitor approved for adults with
ulcerative colitis (UC) and with positive phase 3 data for Crohn's disease (CD). Pediatric off …
ulcerative colitis (UC) and with positive phase 3 data for Crohn's disease (CD). Pediatric off …